Yuanhao Chang

No.119 South 4th Ring Road West
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Novel Thioredoxin reductase 1 inhibitor BS1801 relieves treatment resistance and triggers endoplasmic reticulum stress by elevating reactive oxygen species in glioma.

Novel Thioredoxin reductase 1 inhibitor BS1801 relieves treatment resistance and triggers endoplasmic reticulum stress by elevating reactive oxygen species in glioma.

Journal: Redox biology

Published: June 10, 2025

Epigenetically elevated RAD51AP1 regulates the RAD51-UAF1 complex contributing to temozolomide resistance in EGFRvIII glioblastoma.

Epigenetically elevated RAD51AP1 regulates the RAD51-UAF1 complex contributing to temozolomide resistance in EGFRvIII glioblastoma.

Journal: Chinese medical journal

Published: August 13, 2024

TREM2 is associated with tumor immunity and implies poor prognosis in glioma.

TREM2 is associated with tumor immunity and implies poor prognosis in glioma.

Journal: Frontiers in immunology

Published: November 04, 2022

Galectin-9/TIM-3 as a Key Regulator of Immune Response in Gliomas With Chromosome 1p/19q Codeletion.

Galectin-9/TIM-3 as a Key Regulator of Immune Response in Gliomas With Chromosome 1p/19q Codeletion.

Journal: Frontiers in immunology

Published: October 24, 2021

Molecular Characterization and Clinical Relevance of ANXA1 in Gliomas via 1,018 Chinese Cohort Patients.

Molecular Characterization and Clinical Relevance of ANXA1 in Gliomas via 1,018 Chinese Cohort Patients.

Journal: Frontiers in cell and developmental biology

Published: September 15, 2021

Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples.

Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples.

Journal: Cancer science

Published: June 28, 2021

A potentially effective drug for patients with recurrent glioma: sermorelin.

A potentially effective drug for patients with recurrent glioma: sermorelin.

Journal: Annals of translational medicine

Published: April 12, 2021

High-sensitive clinical diagnostic method for PTPRZ1-MET and the characteristic protein structure contributing to ligand-independent MET activation.

High-sensitive clinical diagnostic method for PTPRZ1-MET and the characteristic protein structure contributing to ligand-independent MET activation.

Journal: CNS neuroscience & therapeutics

Published: September 13, 2020

Uronic acid metabolic process-related gene expression-based signature predicts overall survival of glioma.

Uronic acid metabolic process-related gene expression-based signature predicts overall survival of glioma.

Journal: Bioscience reports

Published: September 01, 2020

Single-Cell RNA-Sequencing Shift in the Interaction Pattern Between Glioma Stem Cells and Immune Cells During Tumorigenesis.

Single-Cell RNA-Sequencing Shift in the Interaction Pattern Between Glioma Stem Cells and Immune Cells During Tumorigenesis.

Journal: Frontiers in immunology

Published: July 08, 2020

Redox Regulator GLRX Is Associated With Tumor Immunity in Glioma.

Redox Regulator GLRX Is Associated With Tumor Immunity in Glioma.

Journal: Frontiers in immunology

Published: July 07, 2020

A novel DNA repair-related nomogram predicts survival in low-grade gliomas.

A novel DNA repair-related nomogram predicts survival in low-grade gliomas.

Journal: CNS neuroscience & therapeutics

Published: June 30, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026